Oral propranolol therapy in parotid hemangiomas: A retrospective comparison with other infantile hemangiomas. 2021

Luying Wang, and Shaohua Li, and Qianqian Gao, and Renrong Lv, and Guangqi Xu, and Xueqing Li, and Jianhai Bi, and Ran Huo
Department of Plastic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

The outcomes of propranolol treatment remain controversial for parotid hemangiomas, which may be inferior to outcomes for infantile hemangiomas (IHs) at other sites. Patients with IHs treated with oral propranolol were retrospectively reviewed. Outcomes of propranolol therapy for parotid hemangiomas and other IHs were examined. Regression models were conducted to analyze the factors associated with the outcomes for parotid hemangiomas. Longer treatment duration was needed for parotid hemangiomas (p = 0.012) at a comparable efficacy and relapse rate as those of IHs at other sites. The higher efficacy was associated with early intervention before 4 months of age (OR = 5.2, p = 0.011), while, the lower relapse rate was associated with adequate treatment duration over 6 months (OR = 9.2, p = 0.010). With a longer propranolol treatment duration, parotid hemangiomas could achieve a comparable efficacy and relapse rate as other IHs. Early treatment initiation and adequate treatment duration benefited the outcomes.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D006391 Hemangioma A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000) Angioma,Chorioangioma,Hemangioma, Histiocytoid,Hemangioma, Intramuscular,Chorangioma,Chorangiomas,Chorioangiomas,Hemangiomas,Hemangiomas, Histiocytoid,Hemangiomas, Intramuscular,Histiocytoid Hemangioma,Histiocytoid Hemangiomas,Intramuscular Hemangioma,Intramuscular Hemangiomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Luying Wang, and Shaohua Li, and Qianqian Gao, and Renrong Lv, and Guangqi Xu, and Xueqing Li, and Jianhai Bi, and Ran Huo
July 2017, The Journal of craniofacial surgery,
Luying Wang, and Shaohua Li, and Qianqian Gao, and Renrong Lv, and Guangqi Xu, and Xueqing Li, and Jianhai Bi, and Ran Huo
January 2011, Pediatric dermatology,
Luying Wang, and Shaohua Li, and Qianqian Gao, and Renrong Lv, and Guangqi Xu, and Xueqing Li, and Jianhai Bi, and Ran Huo
October 2011, The Medical letter on drugs and therapeutics,
Luying Wang, and Shaohua Li, and Qianqian Gao, and Renrong Lv, and Guangqi Xu, and Xueqing Li, and Jianhai Bi, and Ran Huo
January 2016, Scientific reports,
Luying Wang, and Shaohua Li, and Qianqian Gao, and Renrong Lv, and Guangqi Xu, and Xueqing Li, and Jianhai Bi, and Ran Huo
January 2016, Indian journal of dermatology,
Luying Wang, and Shaohua Li, and Qianqian Gao, and Renrong Lv, and Guangqi Xu, and Xueqing Li, and Jianhai Bi, and Ran Huo
November 2020, Pediatric dermatology,
Luying Wang, and Shaohua Li, and Qianqian Gao, and Renrong Lv, and Guangqi Xu, and Xueqing Li, and Jianhai Bi, and Ran Huo
December 2015, Shanghai kou qiang yi xue = Shanghai journal of stomatology,
Luying Wang, and Shaohua Li, and Qianqian Gao, and Renrong Lv, and Guangqi Xu, and Xueqing Li, and Jianhai Bi, and Ran Huo
January 2012, Pediatric dermatology,
Luying Wang, and Shaohua Li, and Qianqian Gao, and Renrong Lv, and Guangqi Xu, and Xueqing Li, and Jianhai Bi, and Ran Huo
January 2011, Pediatric dermatology,
Luying Wang, and Shaohua Li, and Qianqian Gao, and Renrong Lv, and Guangqi Xu, and Xueqing Li, and Jianhai Bi, and Ran Huo
June 2010, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus,
Copied contents to your clipboard!